Genetic Inclusion by Virtual Evaluation

ConditionsBirth Defects Multiple Congenital Anomaly Neurodevelopmental Disorders

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age1-18

SponsorBaylor College of Medicine

About this trial

This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

Whole genome sequencing (WGS)
Diagnostic test
WGS will identify copy number variations (CNVs), single nucleotide variants (SNVs), as well as triplet repeat disorders in children with rare diseases

Treatment groups

200 Participants

are divided into 1 treatment group

Group A: WGS armOther 1 intervention

Trial outcomes

Primary outcomes

Time to diagnosis

Time frame

12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Baylor College of Medicine

Lead sponsor

Source ClinicalTrials.gov

Apply now